O’Connell, Grant
Pritchard, John D.
Prue, Chris
Thompson, Joseph
Verron, Thomas
Graff, Donald
Walele, Tanvir
Funding for this research was provided by:
Imperial Brands plc (NA)
Article History
Received: 4 October 2018
Accepted: 2 January 2019
First Online: 2 February 2019
Compliance with ethical standards
:
: GOC, JDP, CP, JT, TV and TW are full time employees of the Imperial Brands Group. Celerion has received funding from several e-cigarette/tobacco manufacturers to conduct pharmacokinetic/pharmacodynamic studies of their products with smokers and vapers, as well as biomarker studies on smokers who switch to vaping.
: The study is registered at ClinicalTrials.gov (NCT03822546) and a favourable ethical opinion of this study was given by the Institutional Review Board of Chesapeake Research Review (Maryland, USA).
: Participants were presented with an Informed Consent Form and gave written consent to participate at the start of the study.